RPG Life Sciences rises on deal to acquire API business of Raghava Life Sciences

RPG Life Sciences added 1.29% to Rs 2606 after the company said that its subsidiary RPG Active Pharma would acquire the API and intermediates business of Raghava Life Sciences for Rs 135 crore.
Read more at the source

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.